Vanguard Global Advisers’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
Vanguard Global Advisers's IMUX Position: Q3 2026 in Review
Vanguard Global Advisers increased its Immunic (IMUX) stake by 93% in Q3 2026, buying an estimated $40.9K and bringing the position to 6,160 shares worth $57.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3025.
Vanguard Global Advisers first reported a position in IMUX in Q1 2026 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.
- Vanguard Global Advisers held 6,160 shares of Immunic worth $57.3K as of Q3 2026.
- Vanguard Global Advisers bought 2,974 Immunic shares in Q3 2026, an estimated $40.9K.
- Immunic made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3025 holding.
- Vanguard Global Advisers first reported a position in Immunic in Q1 2026 and has held it in 3 quarters since.
- 78 funds tracked by Wall St. Rank held Immunic as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.